Source:http://linkedlifedata.com/resource/pubmed/id/19053751
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2008-12-18
|
pubmed:abstractText |
Dual inhibition of the prostaglandin (PG) and leukotriene (LT) biosynthetic pathway is supposed to be superior over single interference, both in terms of efficacy and side effects. Here, we present a novel class of dual microsomal PGE(2) synthase-1/5-lipoxygenase (5-LO) inhibitors based on the structure of pirinixic acid [PA, 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)acetic acid, compound 1]. Target-oriented structural modification of 1, particularly alpha substitution with extended n-alkyl or bulky aryl substituents and concomitant replacement of the 2,3-dimethylaniline by a biphenyl-4-yl-methane-amino residue, resulted in potent suppression of mPGES-1 and 5-LO activity, exemplified by 2-(4-(biphenyl-4-ylmethylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (7b, IC(50) = 1.3 and 1 microM, respectively). Select compounds also potently reduced PGE(2) and 5-LO product formation in intact cells. Importantly, inhibition of cyclooxygenases-1/2 was significantly less pronounced. Taken together, these pirinixic acid derivatives constitute a novel class of dual mPGES-1/5-LO inhibitors with a promising pharmacological profile and a potential for therapeutic use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Intramolecular Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/pirinixic acid,
http://linkedlifedata.com/resource/pubmed/chemical/prostaglandin-E synthase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8068-76
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19053751-Cell Line, Tumor,
pubmed-meshheading:19053751-Cell Survival,
pubmed-meshheading:19053751-Chemistry, Pharmaceutical,
pubmed-meshheading:19053751-Cyclooxygenase 1,
pubmed-meshheading:19053751-Cyclooxygenase 2,
pubmed-meshheading:19053751-Drug Design,
pubmed-meshheading:19053751-Enzyme Activation,
pubmed-meshheading:19053751-Enzyme Inhibitors,
pubmed-meshheading:19053751-Humans,
pubmed-meshheading:19053751-Inflammation,
pubmed-meshheading:19053751-Inhibitory Concentration 50,
pubmed-meshheading:19053751-Intramolecular Oxidoreductases,
pubmed-meshheading:19053751-Lipoxygenase Inhibitors,
pubmed-meshheading:19053751-Models, Chemical,
pubmed-meshheading:19053751-Pyrimidines
|
pubmed:year |
2008
|
pubmed:articleTitle |
Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
|
pubmed:affiliation |
Department of Pharmaceutical Analytics, Pharmaceutical Institute, Eberhard-Karls-University Tuebingen, Auf der Morgenstelle 8, D-72076 Tuebingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|